Anthem Blue Cross Blue Shield of Georgia policy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy is a public Anthem Blue Cross Blue Shield of Georgia policy (policy LAB.00042). It lists 1 CPT or HCPCS code, 0 of them on the Anthem Blue Cross Blue Shield of Georgia prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- LAB.00042
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of Georgia prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross Blue Shield of Georgia policies |
|---|---|---|---|
| 81599 | Not listed | Policies naming 81599 |
All Anthem Blue Cross Blue Shield of Georgia policies · Anthem Blue Cross Blue Shield of Georgia prior authorization CPT list